Resumen
Vaccine mediated immune mediated thrombocytopenia (ITP) is exceedingly rare. We present a case of a young female who developed severe refractory ITP with multiple bleeding sites post second dose of COVID-19 vaccination. She was treated with a combination of romiplostim and mycophenolate mofetil that resulted in rapid platelet count recovery.
| Idioma original | English |
|---|---|
| Número de artículo | e05035 |
| Publicación | Clinical Case Reports |
| Volumen | 9 |
| N.º | 11 |
| DOI | |
| Estado | Published - nov 2021 |
Nota bibliográfica
Publisher Copyright:© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- General Medicine
Huella
Profundice en los temas de investigación de 'Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID-19 vaccination'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver